0000899243-19-011289.txt : 20190426
0000899243-19-011289.hdr.sgml : 20190426
20190426195835
ACCESSION NUMBER: 0000899243-19-011289
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190424
FILED AS OF DATE: 20190426
DATE AS OF CHANGE: 20190426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelley Lynne E
CENTRAL INDEX KEY: 0001667584
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 19773380
MAIL ADDRESS:
STREET 1: 20451 SENECA MEADOWS PARKWAY
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 955 MASSACHUSETTS AVENUE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 955 MASSACHUSETTS AVENUE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-24
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001667584
Kelley Lynne E
C/O X4 PHARMACEUTICALS, INC.
955 MASSACHUSETTS AVENUE, 4TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
20.30
2019-04-24
4
A
0
37170
0.00
A
2029-04-24
Common Stock
37170
37170
D
25% of the shares subject to the option shall vest on April 24, 2020, with the remainder vesting in equal installments of 2.083% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
/s/ Adam S. Mostafa, attorney-in-fact
2019-04-26